Use of Livarol (vaginal suppositories) to prevent chronic recurrent candidiasis caused by non-albicans Candida spp.


Cite item

Full Text

Abstract

The paper gives the results of studying the efficacy and safety of Livarol (vaginal suppositories containing ketoconazole 400 mg) in preventing a relapse of chronic recurrent genital candidiasis caused by non-albicans Candida spp. Thirty women aged 18-59 years (mean 33.8±8.7 years) who had at least four relapses for a year and pathogens that are not Candida albicans, which had been confirmed by laboratory data, (a study group) were examined. A control group comprised 220 patients aged 18 to 62 years (mean 30.±8.7 years) who had not received preventive antirecurrent treatment. In the study group, the causative agents were C. krusei (27%), C. tropicalis (26%), and C. glabrata (23%); in the control group, these were C. albicans (83%), C. glabrata (5.2%), and C. krusei (4.8%). The clinical and mycological efficiency of the antirecurrent use of Livarol for 6 months was 93.4%. With the use of Livarol, a remission 12 months after relapse arrest was noted in 86.7% of the women in the study group and in 25% in the control group (p < 0.05).

About the authors

A K Mirzabalayeva

Saint Petersburg Medical Academy of Postgraduate Education, Russian Agency for Health Care

Кафедра клинической микологии, аллергологии и иммунологиидоктор медицинских наук, профессор; ГОУ ДПО Санкт-Петербургская медицинская академия последипломного образования Росздрава; Saint Petersburg Medical Academy of Postgraduate Education, Russian Agency for Health Care

O N Zhorzh

Russian State Medical Academy of Postgraduate Education, Moscow

Russian State Medical Academy of Postgraduate Education, Moscow

N N Klimko

Saint Petersburg Medical Academy of Postgraduate Education, Russian Agency for Health Care

Кафедра клинической микологии, аллергологии и иммунологии; ГОУ ДПО Санкт-Петербургская медицинская академия последипломного образования Росздрава; Saint Petersburg Medical Academy of Postgraduate Education, Russian Agency for Health Care

References

  1. Климко Н. Н. Микозы: диагностика и лечение: Руководство для врачей. - 2-е изд. - М., 2008.
  2. Долго-Сабурова Ю. В., Мирзабалаева А. К., Васильева Н. В. и др. // Пробл. мед. микол. - 2005. - Т. 7, № 3. - С. 12-15.
  3. Долго-Сабурова Ю. В. Клинико-лабораторные особенности хронического рецидивирующего кандидоза гениталий у женщин: Автореф. дис. ... канд. мед. наук. - СПб., 2006.
  4. Захарова Т. П. // Consilium Medicum. - 2004. - Экстравып.: Симпозиум "Микозы. Рациональная фармакотерапия". - С. 10-14.
  5. Кисина В. И. // Consilium Medicum. Дерматол. и венерол. - 2002. - Т. 6, № 2. - С. 5-9.
  6. Липова Е. В. // Гинекология. - 2008. - Т. 10, № 5. - С. 35-38.
  7. Мирзабалаева А. К., Долго-Сабурова Ю. В., Жорж О. Н. и др. // Вопр. гин., акуш. и перинатол. - 2008. - Т. 7, № 1. - С. 47-52.
  8. Прилепская В. Н. Отчет о клиническом исследовании препарата "Ливарол". - М., 2006.
  9. Тихомиров А. Л., Олейник Ч. Г. // Эффектив. фармакотер. в акуш. и гин. - 2007. - № 4. - С. 23-28.
  10. Asticcioli S., Mighiavacca R., Nucleo E. et al. // Clin. Microbiol. Infect. - 2004. - Vol. 10, Suppl. 3. - P. 266.
  11. Jilek P., Spasek J. et al. // 3-rd Trends in Medical Mycology. - Turin, 2007. - P. 99.
  12. Mardh P. A., Rodrigues A. G., Gens N. et al. // Int. J. STD AIDS. - 2002. - Vol. 13. - P. 522-539.
  13. Patel D. A., Gillespie B., Sobel J. D. et al. // Am. J. Obstetr. Gynecol. - 2004. - Vol. 190, N 3. - P. 644-653.
  14. Sobel J. D. Mucocutaneous Candidiasis in Infectious Diseases. - New York, 2000.
  15. Sobel J. D., Zervos M., Reed B. D. et al. // Antimicrob. Agents Chemother. - 2003. - Vol. 47, N 1. - P. 34-38.
  16. Sobel J. D., Wiesenfeld H. C., Martens M. et al. // N. Engl. J. Med. - 2004. - Vol. 351. - P. 876-883.
  17. Stamm W. E. // Clin. Infect. Dis. - 2007. - Vol. 44. - P. 775-776.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies